• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4635977)   Today's Articles (648)   Subscriber (50069)
For: Rychert M, Wilkins C. The challenge of a ban on animal testing for the development of a regulated legal market for new psychoactive substances (NPS) (‘legal highs’) in New Zealand: Issues and options for resolution. International Journal of Drug Policy 2015;26:1273-8. [DOI: 10.1016/j.drugpo.2015.08.006] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/24/2015] [Accepted: 08/05/2015] [Indexed: 11/28/2022]
Number Cited by Other Article(s)
1
Johnson CS, Shadfar Z, Allison JR, Walsh KAJ, Partington HK. Controlling new psychoactive substances in New Zealand. AUST J FORENSIC SCI 2022. [DOI: 10.1080/00450618.2022.2067230] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
2
Robson H, Braund R, Glass M, Ashton J, Tatley M. Synthetic cannabis: adverse events reported to the New Zealand Pharmacovigilance Centre. Clin Toxicol (Phila) 2020;59:472-479. [DOI: 10.1080/15563650.2020.1828592] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/23/2023]
3
Rychert M, Wilkins C. Understanding the development of a regulated market approach to new psychoactive substances (NPS) in New Zealand using Punctuated Equilibrium Theory. Addiction 2018;113:2132-2139. [PMID: 29744945 DOI: 10.1111/add.14260] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/10/2017] [Revised: 01/24/2018] [Accepted: 04/25/2018] [Indexed: 12/01/2022]
4
Rychert M, Wilkins C. A critical analysis of the implementation of a legal regulated market for new psychoactive substances (“legal highs”) in New Zealand. THE INTERNATIONAL JOURNAL OF DRUG POLICY 2018. [DOI: 10.1016/j.drugpo.2018.02.014] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
5
Rychert M, Wilkins C, Parker K, Witten K. Are government-approved products containing new psychoactive substances perceived to be safer and more socially acceptable than alcohol, tobacco and illegal drugs? Findings from a survey of police arrestees in New Zealand. Drug Alcohol Rev 2017;37:406-413. [DOI: 10.1111/dar.12655] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/28/2017] [Revised: 11/28/2017] [Accepted: 12/02/2017] [Indexed: 11/29/2022]
6
Cairns R, Brown JA, Gunja N, Buckley NA. The impact of Australian legislative changes on synthetic cannabinoid exposures reported to the New South Wales Poisons Information Centre. THE INTERNATIONAL JOURNAL OF DRUG POLICY 2017;43:74-82. [DOI: 10.1016/j.drugpo.2017.02.008] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/05/2016] [Revised: 01/06/2017] [Accepted: 02/26/2017] [Indexed: 12/26/2022]
7
Rychert M, Wilkins C, Witten K. “Lost in translation”: Issues with the establishment of a legal market for “low risk” psychoactive products (“legal highs”) in New Zealand. DRUGS-EDUCATION PREVENTION AND POLICY 2017. [DOI: 10.1080/09687637.2017.1282422] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
8
Barratt MJ, Seear K, Lancaster K. A critical examination of the definition of ‘psychoactive effect’ in Australian drug legislation. THE INTERNATIONAL JOURNAL OF DRUG POLICY 2017;40:16-25. [DOI: 10.1016/j.drugpo.2016.10.002] [Citation(s) in RCA: 27] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/18/2016] [Revised: 09/08/2016] [Accepted: 10/18/2016] [Indexed: 11/29/2022]
9
Wilkins C, Rychert M. Recent developments with the New Zealand regulated market approach to 'low-risk' psychoactive products. Addiction 2017;112:34-36. [PMID: 27457711 DOI: 10.1111/add.13495] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/08/2016] [Accepted: 06/09/2016] [Indexed: 11/29/2022]
10
Legal high industry business and lobbying strategies under a legal market for new psychoactive substances (NPS, ‘legal highs’) in New Zealand. THE INTERNATIONAL JOURNAL OF DRUG POLICY 2016;37:90-97. [DOI: 10.1016/j.drugpo.2016.08.011] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/24/2016] [Revised: 08/16/2016] [Accepted: 08/18/2016] [Indexed: 11/18/2022]
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA